OPK News and Press, Opko Health Inc. From 10/20/23

2023-10-20 13:30:50 ET Summary OPK and PFE received FDA approval for Ngenla in June. This enables OPK to receive royalties going forward. OPK has continued to lose money due to its lab business. The business had sales fall off following the decline in COVID testing. OPK needs to r...

NextPlat (NASDAQ: NXPL, NXPLW) , a global e-commerce provider, today announced that, through a new e-commerce distribution agreement, it will enable the online sales of OPKO Health Europe, a subsidiary of OPKO Health (NASDAQ: OPK) products in China. Under the agreement terms, NextPlat will laun...

New E-Commerce Agreement Enables NextPlat to Offer OPKO's Nutraceutical and Veterinary Products for Sale to Chinese Consumers COCONUT GROVE and MIAMI, FL / ACCESSWIRE / October 12, 2023 / NextPlat Corp (NASDAQ:NXPL)(NASDAQ:NXPLW) ("NextPlat" or the "Company"), a global e-commerce provider, t...

2023-09-29 06:47:00 ET Summary Nike's profit beat estimates, causing the stock to rise 8% premarket, but China sales fell short. Exelon and its subsidiary ComEd have agreed to pay a $46.2M civil penalty to settle fraud charges. Tesla and Chipotle are facing lawsuits from the E...

2023-09-29 05:36:01 ET Related stories: NIKE, Inc. (NKE) Q1 2024 Earnings Call Transcript Nike in charts: Q1 footwear revenue climbs from last year, but dips from Q4 Nike Earnings Preview: Low Expectations With Poor Sentiment; Comps Get Easier In FY '24 Edita...

2023-09-29 04:41:48 ET ModeX Therapeutics, an OPKO Health ( NASDAQ: OPK ) company, has been awarded a contract from the Biomedical Advanced Research and Development Authority, to advance a platform and specific candidates designed to address a range of public health threats in vir...

NATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. company (NASDAQ: OPK), has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at th...

JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK, “OPKO”) have entered into a Research Collaboration Agreement. Under the terms of the Agreement, OPKO will su...

2023-09-09 03:17:14 ET Summary Wall Street underestimates the prospects of Pfizer and Gilead Sciences, given their significant role in developing vaccines and medicines against COVID-19. Gilead Sciences' revenue has remained stable in recent quarters, unlike Pfizer, whose demand f...

2023-08-04 01:00:22 ET Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q2 2023 Earnings Call Aug 03, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q2 2023 Earnings Call Transcript